A. Pouliquen

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

Ousmane A Camara, C. Carel, P. Vermersch, 2022, Neurology and Therapy.

Oral sedation in dentistry: evaluation of professional practice of oral hydroxyzine in the University Hospital of Rennes, France

V. Meuric, A. Pouliquen, E. Boyer, 2021, European Archives of Paediatric Dentistry.